- Conditions
- New Daily Persistent Headache
- Interventions
- OnabotulinumtoxinA
- Drug
- Lead sponsor
- St. Luke's-Roosevelt Hospital Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- New York, New York
Source: ClinicalTrials.gov public record
Updated Oct 25, 2016 · Synced May 22, 2026, 5:44 AM EDT